lohexol

Product Details

Category: Contrast media
API Name: lohexol; 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N~1~,N~3~-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-

CAS NO: 66108-95-0

Formula: C₁₉H₂₆I₃N₃O₉

MW: 820.9

Spec.: USP/EP/JP latest

DMF: US-DMF, E-DMF

GMP: cGMP; CoPP; EIR

FAQ

What products does Haizhou Pharma manufacture and supply globally?
Haizhou Pharma manufactures APIs, pharmaceutical intermediates, fine chemicals, and iodinated contrast media products for global pharmaceutical and healthcare markets.
Which industries and applications does Haizhou Pharma mainly serve?
We serve pharmaceutical, healthcare, medical imaging, and specialty chemical industries with products used in formulation, diagnostics, and therapeutic applications.
What are Haizhou Pharma’s core technology and product strengths?
Our core strengths include Guaiacol derivatives, Epichlorohydrin derivatives, and contrast media APIs, supported by decades of manufacturing and process expertise.
Does Haizhou Pharma provide CDMO and custom manufacturing services?
Yes. We offer flexible CDMO and custom manufacturing solutions for both GMP and non-GMP projects with dedicated technical and project management teams.
What international certifications and regulatory approvals does Haizhou Pharma hold?
Haizhou Pharma holds GMP, FDA, EDQM, MFDS, ISO 14001, ISO 45001, COPP certifications, and received the 2024 EcoVadis Silver Medal.
How strong is Haizhou Pharma’s research and development capability?
We operate three specialized R&D centers focused on process optimization, analytical validation, new product development, and CDMO collaboration projects.